News First new Parkinson's treatment in decade gains US approval Newron's Xadago, a new add-on treatment for patients with Parkinson's disease, has been approved by the FDA.
News Outrage at Marathon's 'new drug' price, calls for PhRMA to a... Marathon under fire after US price hike.
R&D Proving ROI for digital endpoints The costs associated with clinical trials are a major bottleneck to drug development and affordability.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.